Volume 13, Number 4—April 2007
Dispatch
16S rRNA Methylase–producing, Gram-Negative Pathogens, Japan
Kunikazu Yamane*, Jun-ichi Wachino*, Satowa Suzuki*, Naohiro Shibata*, Haru Kato*, Keigo Shibayama*, Kouji Kimura*, Kumiko Kai*, Satoshi Ishikawa*, Yoshiyuki Ozawa*, Toshifumi Konda*, and Yoshichika Arakawa*
Table 3
MICs of antimicrobial agents for arbekacin-resistant strains*†‡
| Strain no. | MIC (mg/L) |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABK | AMK | TOB | ISP | GEN | SM | NEO | CTX | CAZ | IPM | CIP | |
| 40 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 8 | >1,024 | <0.06 | 0.125 | 0.125 | 64 |
| 64 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 8 | >1,024 | <0.06 | 0.5 | 0.125 | 64 |
| 101 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 32 | >1,024 | 8 | 2 | 0.5 | 32 |
| 103 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 32 | 16 | 64 | 2 | 0.5 | <0.06 |
| 109 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 8 | 16 | 64 | 16 | 0.5 | <0.06 |
| 113 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 128 | 512 | 16 | 2 | 16 | 0.125 |
| 127 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 128 | 128 | 16 | 2 | 16 | <0.06 |
| 157 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 32 | 32 | 64 | 4 | 2 | 0.5 |
| 158 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 128 | 512 | 32 | 8 | 16 | 0.125 |
| 231 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 32 | >128 | 128 | 4 | 16 |
| 249 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 256 | 512 | 16 | 1 | 4 | <0.06 |
| 252 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 512 | 512 | 128 | 4 | 4 | 8 |
| 328 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 8 | 512 | >128 | >128 | 2 | 32 |
| 353 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 32 | 256 | 64 | >128 | 4 | 32 |
| 386 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 256 | 256 | 128 | >128 | 0.5 | >128 |
| 422 | >1,024 | >1,024 | >1,024 | 256 | >1,024 | 512 | >1,024 | >128 | >128 | 8 | 128 |
| 463 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 64 | 128 | 16 | 4 | 8 | 32 |
| 469 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 64 | 32 | >128 | 8 | 0.25 | <0.06 |
| 470 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 128 | 8 | >128 | >128 | 4 | 1 |
| 471 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 64 | 8 | 128 | 4 | 0.25 | <0.06 |
| 479 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 256 | 1,024 | 64 | 4 | 0.25 | 0.25 |
| 499 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 64 | 4 | 0.06 | 0.125 | 0.25 | 0.25 |
| 509 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 64 | 1 | >128 | 64 | 0.25 | 125 |
| 525 | 512 | 512 | 1,024 | 512 | 256 | >1,024 | >1,024 | 128 | 32 | 16 | >128 |
| 527 | 1,024 | 512 | 1,024 | >1,024 | 64 | >1,024 | >1,024 | >128 | >128 | 128 | 0.125 |
| 593 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 128 | 64 | >128 | 128 | 2 | 0.5 |
| 615 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 16 | >128 | >128 | 1 | 32 |
| 617 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 32 | >128 | >128 | 1 | 32 |
| 619 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | >1,024 | 32 | >128 | >128 | 1 | 32 |
*ABK, arbekacin; AMK, amikacin; TOB, tobramycin; ISP, isepamycin; GEN, gentamicin; SM, streptomycin; NEO, neomycin; CTX,
cefotaxime; CAZ, ceftazidime; IPM, imipenem; CIP, ciprofloxacin.
†MICs of kanamycin and sisomycin are not listed because values are >1,024 for all strain numbers.
‡See Table 2 for bacterial species and PCR type of 16S rRNA methylase gene of each strain number.
Page created: June 25, 2010
Page updated: June 25, 2010
Page reviewed: June 25, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.